What does global health stem from, when is it born, how does it relate to the
contemporary world order? This book explores the origins of global health, a new
regime of health intervention in countries of the global South, born around
1990. It proposes an encompassing view of the transition from international
public health to global health, bringing together historians and anthropologists
to explore the relationship between knowledge, practices and policies. It aims
at interrogating two gaps left by historical and anthropological studies of the
governance of health outside Europe and North America. The first is a temporal
gap between the historiography of international public health through the 1970s
and the numerous anthropological studies of global health in the present. The
second originates in problems of scale. Macro-inquiries of institutions and
politics, and micro-investigations of local configurations, abound. The book
relies on a stronger engagement between history and anthropology, i.e. the
harnessing of concepts (circulation, scale, transnationalism) crossing both of
them, and on four domains of intervention: tuberculosis, mental health, medical
genetics and traditional (Asian) medicines. The volume analyses how the new
modes of ‘interventions on the life of others’ recently appeared, why they blur
the classical divides between North and South and how they relate to the more
general neoliberal turn in politics and economy. The book is meant for
academics, students and health professionals interested in new discussions about
the transnational circulation of drugs, bugs, therapies, biomedical technologies
and people in the context of the ‘neoliberal turn’ in development practices.
Claire Beaudevin, Jean-Paul Gaudillière, Christoph Gradmann, Anne M. Lovell, and Laurent Pordié
The phrase ‘globalhealth’ appears ubiquitously in contemporary medical spheres, from academic research programmes to websites of pharmaceutical companies. In its most visible manifestation, globalhealth refers to strategies addressing major epidemics and endemic conditions through philanthropy (e.g. the Bill and Melinda Gates Foundation) and multilateral, public-private partnerships (e.g. the Global Fund against AIDS, Tuberculosis and Malaria). Within this context, globalhealth can be understood as a series of concerted responses to the
The emerging relationship between genomics and a terrain of globalhealth aligns arenas of social practice, cultural meaning and political value that might until recently have seemed antithetical. Developments in genomic research and medicine since the turn of the twenty-first century have long been associated with the promises of so-called personalized medicine, linked mostly to costly, high-end technological interventions focused on facilitating the choice of individual patients and their families who have
Diplomatic Corps, autism researchers, advocates and political
representatives including Sarah Brown, wife of the then British
prime minister, Gordon Brown, and Ban Soon-taek, wife of United
Nations Secretary General Ban Ki-moon, who chaired the discussions.
Suzanne Wright, co-founder of the charity Autism Speaks, stated
that, ‘ Autism is a globalhealth crisis that knows no
Debates Surrounding Ebola Vaccine Trials in Eastern Democratic Republic of
Myfanwy James, Joseph Grace Kasereka, and Shelley Lees
exceptional emergency, it was acceptable ‘on both ethical and evidential
grounds’ to test vaccines which had promising results in laboratory and
animal models ( Kelly, 2018 : 148). Debate
followed among globalhealth institutions about the best design for such
experimental interventions. Some held that only randomised, placebo-controlled
trials could produce robust evidence of efficacy; others argued that withholding
potentially effective treatment from patients was ethically
A Belated but Welcome Theory of Change on Mental Health and
set out such strategic guidance ‘for the first time’
five years into the SDGs. In the current globalhealth crisis which has so starkly
exposed the fragility of mental health and underscored the interrelation between
mental and physical health, and between health and its social determinants, the ToC
for use by development and humanitarian sectors has come not a moment too soon. I
suggest that two outputs within the document are key to achieving the quality
’, Bulletin of the World Health
Organization , 99 : 6 ,
473 – 4 , doi: 10.2471/BLT.20.269464 .
Dahl , E.
et al . ( 2021 ),
‘ Control of Visceral Leishmaniasis in East Africa:
Fragile Progress, New Threats ’, BMJ GlobalHealth , 6 , e006835 , doi:
This book explains the current fascination with autism by linking it to a longer history of childhood development. Drawing from a staggering array of primary sources, it traces autism back to its origins in the early twentieth century and explains why the idea of autism has always been controversial and why it experienced a 'metamorphosis' in the 1960s and 1970s. The book locates changes in psychological theory in Britain in relation to larger shifts in the political and social organisation of schools, hospitals, families and childcare. It explores how government entities have dealt with the psychological category of autism. The book looks in detail at a unique children's 'psychotic clinic' set up in London at the Maudsley Hospital in the 1950s. It investigates the crisis of government that developed regarding the number of 'psychotic' children who were entering the public domain when large long-stay institutions closed. The book focuses on how changes in the organisation of education and social services for all children in 1970 gave further support to the concept of autism that was being developed in London's Social Psychiatry Research Unit. It also explores how new techniques were developed to measure 'social impairment' in children in light of the Seebohm reforms of 1968 and other legal changes of the early 1970s. Finally, the book argues that epidemiological research on autism in the 1960s and 1970s pioneered at London's Institute of Psychiatry has come to define global attempts to analyse and understand what, exactly, autism is.
concerns this journal, the humanitarian sector faces its
own challenges when navigating the globalhealth environment and responding to outbreaks
of infectious disease.
The first contribution to this issue is a research article by Myfanwy James et
al. that digs through the debates surrounding Ebola vaccine trials in the
eastern Democratic Republic of Congo. The focus is on the introduction of a second
experimental vaccine and the related ethical dilemmas of doing so in an epidemic
Frédéric Le Marcis, Luisa Enria, Sharon Abramowitz, Almudena-Mari Saez, and Sylvain Landry B. Faye
3 – 33 , doi: 10.1177/000203971004500201 .
Gillespie , A.
Asawi , R.
( 2016 ), ‘ Social
Mobilization and Community Engagement Central to the Ebola Response in West
Africa: Lessons for Future Public Health
Emergencies ’, GlobalHealth